Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanchitongshu for Prevention of High-risk Ischemic Stroke Recurrence
NCT04142151Unknown
- Sponsor
- Xinhua Hospital
- Start
- Sep 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in ischemic stroke comparing SanchiTongshu group with SanchiTongshu Placebo group (2 arms). Primary endpoint: New stroke attack at 24 hours. Status: unknown.
02
Drugs
sanqi tongshu
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04142151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04142151.